arrow
M

Martin Kršák

university of colorado
H指数:18
被引数:985

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

大肠杆菌ST131驱动了大肠杆菌血流感染中使用碳青霉烯类药物。

2026-03-060
PRE
2025 ICM: Diagnostic Techniques: Molecular Tests

2025 ICM:诊断技术:分子检测

2025-11-010
PRE
2025 ICM: Minimal Biofilm Eradication Concentration (MBEC) versus Minimum Inhibitory Concentration (MIC)

2025 ICM:最小生物膜清除浓度(MBEC)与最低抑菌浓度(MIC)

2025-10-310
PRE
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders

采用致幻剂团体疗法治疗工作相关压力:一项关于为医疗保健工作者和一线应急响应人员进行的团体氯胺酮辅助心理治疗的病例系列

2025-10-140
OA
Impact of Substance Use Disorders on Outcomes of Medically Insured Persons Receiving Multiweek Outpatient Parenteral Antimicrobial Therapy: a Claims-based Cohort Study From 2015 to 2020

物质使用障碍对接受多周期门诊静脉抗菌药物治疗的医疗投保人员结局的影响:一项基于2015年至2020年理赔数据的队列研究

2025-06-010
OAAI
National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals
2024-04-162
OAAI
Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study

头孢曲松耐药对大肠埃希菌血流感染的临床影响: 一项多中心前瞻性队列研究

2022-10-278
OAAI